Standout Papers
Immediate Impact
9 by Nobel laureates 35 from Science/Nature 76 standout
Citing Papers
Gene Editing for CEP290 -Associated Retinal Degeneration
2024 Standout
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Works of Daniel C. Chung being referenced
How long does gene therapy last? 4-year follow-up of phase 3 voretigene neparvovec trial in RPE65-associated LCA/inherited retinal disease
2019
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel C. Chung | 2494 | 865 | 791 | 70 | 3.3k | |
| Michael L. Robinson | 3823 | 537 | 884 | 104 | 5.4k | |
| Douglas B. Gould | 1908 | 871 | 789 | 69 | 3.8k | |
| Amir Rattner | 4048 | 644 | 636 | 62 | 5.3k | |
| M. Sarfarazi | 1697 | 410 | 806 | 65 | 2.9k | |
| John R.W. Yates | 2193 | 1213 | 1418 | 80 | 5.3k | |
| Jochen Graw | 3931 | 1017 | 1327 | 158 | 5.6k | |
| Lihua Y. Marmorstein | 2319 | 1057 | 925 | 47 | 3.4k | |
| Alfons Meindl | 3400 | 402 | 2006 | 76 | 5.6k | |
| Hélène Dollfus | 4736 | 1218 | 2890 | 175 | 6.6k | |
| Lies H. Hoefsloot | 3558 | 534 | 1663 | 135 | 6.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...